Shares of Hi-Tech Pharmacal (HITK -18.1%) fall off sharply after rival Wockhardt says it landed...

|About: Hi-Tech Pharmacal Co., Inc. (HITK)|By:, SA News Editor

Shares of Hi-Tech Pharmacal (HITK -18.1%) fall off sharply after rival Wockhardt says it landed FDA approval for a generic copy of GlaxoSmithKline's Flonase nasal spray in a development that could dampen sales of the firm's own generic offering.